This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Did the SYNTAX Trial Change Practice in the United States?

Tuesday, March 29, 2016

Joseph Sabik of the Cleveland Clinic, Cleveland, Ohio, considers whether the SYNTAX trial changed cardiology and cardiothoracic surgery practice in the United States. He discusses whether the SYNTAX trial findings appropriately affected the use of CABG versus PCI.

This presentation was originally given during the SCTS Ionescu University program at the 2015 Annual Meeting of the Society for Cardiothoracic Surgery in Great Britain and Ireland. This content is published with the permission of SCTS. Please click here for more information on SCTS educational programs. 


The only reported impact of SYNTAX was the more use of PCI for left main. There is no point of doing trials if they do not impact real change in practice for the benefit of our patients. The basic problem is not the availability of evidence .the problem is the fact that cardiologists are the gate controllers and they are not saints.
There has to be a way. There is a treatment modality recommended in the light of research and patients can't benefit from it the they should. There has to be a way to deal this. After all we love in 21st century.
Congratulations Joseph was a very good information a very good option is work together more in benefit of the patients with a Heart Team how we and others are doing ,basically doing the left internal mammary to the LAD with the Mini Opcabg or Midcab operation and after stenting and use the best of boths worlds a lot of patients will prefer this option for sure instead of a big operation open all the chest on pump etc

Add comment

Log in or register to post comments